Skip to main content

Peer Review reports

From: The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus – outcomes from cross‐over open-label randomized trial

Original Submission
18 Jan 2021 Submitted Original manuscript
1 Feb 2021 Author responded Author comments - Pavle Vrebalov Cindro
Resubmission - Version 2
1 Feb 2021 Submitted Manuscript version 2
15 Feb 2021 Reviewed Reviewer Report
20 Feb 2021 Reviewed Reviewer Report
26 Feb 2021 Reviewed Reviewer Report
17 Mar 2021 Author responded Author comments - Pavle Vrebalov Cindro
Resubmission - Version 3
17 Mar 2021 Submitted Manuscript version 3
21 Mar 2021 Reviewed Reviewer Report
26 Mar 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Apr 2021 Editorially accepted
29 Apr 2021 Article published 10.1186/s12902-021-00746-1

You can find further information about peer review here.

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us